Agency Forms Undergoing Paperwork Reduction Act Review, 60043-60047 [2021-23555]
Download as PDF
<![CDATA[
60043
Federal Register / Vol. 86, No. 207 / Friday, October 29, 2021 / Notices
program implementation capacity,
leveraged resources/funds through
economic indicators, and challenges
and successes, programmatic
improvements, and impact through
interviews. Finally, awardees will
annually submit injury and violence
prevention surveillance data using
Excel-based Injury Indicator
Spreadsheets and Special Emphasis
Reports.
Information to be collected will
provide crucial data for program
evaluation and provide CDC with the
ability to respond in a timely manner to
requests for information about the
program from the Department of Health
and Human Services (HHS), the White
House, Congress, and others. Data from
the collection will also be used by CDC
to increase capacity, understand how
the cooperative agreement increases
potential sustainability though
improved capacity, provide data-driven
technical assistance, and disseminate
the most current surveillance data on
unintentional and intentional injuries.
Authority for CDC’s National Center
for Injury Prevention and Control
(NCIPC) to collect these data is granted
by Section 301 of the Public Health
Service Act (42 U.S.C. 241). This Act
gives federal health agencies, such as
CDC, broad authority to collect data and
to participate in other public health
activities, including program
implementation evaluation. The Core
SIPP evaluation will collect several
types of information from recipients
over the course of the funding cycle.
This information will be used to:
(1) Evaluate and track outcomes at the
recipient- and program-levels as they
relate to injury prevention-focused
infrastructure development,
surveillance system development and
use, and partnerships, to prevent
Adverse Childhood Experiences (ACEs),
Traumatic Brain Injury (TBI), and
transportation-related injuries.
Recipient-and program-level
identification of disproportionately
affected populations and subsequent
public health actions taken to address
injury-related health disparities will
also be assessed.
(2) Identify technical assistance needs
of individual recipients and this
recipient cohort, so that the CDC team
can appropriately deploy resources to
support recipients.
(3) Identify practice-based evidence
for injury prevention public health
actions to advance the field through
future partnerships, program design,
and publications.
(4) Inform continuous quality
improvement activities over the course
of the funding period, to include
quarterly and annual strategic planning
for current and later iterations of this
program under future funding.
CDC requests approval for 679 total
estimated annualized burden hours.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Core SIPP Program Awardees
Implementation Capacity Development Rubric ......................
Economic Indicators ...............................................................
Recipient-level Group Interviews ...........................................
Injury Indicators Spreadsheet ................................................
Emergency Department Injury Indicators Spreadsheet .........
Hospital Discharge Injury Indicators Spreadsheet .................
Special Emphasis Reports .....................................................
Jeffrey M. Zirger,
Lead,Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–23554 Filed 10–28–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1355]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
submitted the information collection
request titled Phased Approach to the
Resumption of Cruise Ship Passenger
Operations to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
VerDate Sep<11>2014
18:17 Oct 28, 2021
Jkt 256001
Number of
respondents
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ on April 30, 2021,
to obtain comments from the public and
affected agencies. This collection
accompanies a CDC Order entitled
Temporary Extension and Modification
of Framework for Conditional Sailing
Order (CSO). CDC received twenty (20)
comments related to the previous
notice. This notice serves to allow an
additional 30 days for public and
affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary for the
proper performance of the functions of the
agency, including whether the information
will have practical utility;
(b) Evaluate the accuracy of the agencies
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and assumptions
used;
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
23
23
23
23
23
23
23
Number of
responses per
respondent
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
2
1
1.5
5
5
5
10
(c) Enhance the quality, utility, and clarity
of the information to be collected;
(d) Minimize the burden of the collection
of information on those who are to respond,
including, through the use of appropriate
automated, electronic, mechanical, or other
technological collection techniques or other
forms of information technology, e.g.,
permitting electronic submission of
responses; and
(e) Assess information collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
E:\FR\FM\29OCN1.SGM
29OCN1
60044
Federal Register / Vol. 86, No. 207 / Friday, October 29, 2021 / Notices
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Phased Approach to the Resumption
of Cruise Ship Passenger Operations
(OMB Control No. 0920–1335, Exp. 10/
31/2021)—Extension—National Center
for Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
khammond on DSKJM1Z7X2PROD with NOTICES
Background and Brief Description
The Temporary Extension and
Modification Framework for
Conditional Sailing Order (here on
referred to as the ‘‘CSO Extension’’)
extends The Framework for Conditional
Sailing Order published in the Federal
Register on November 4, 2020, and
continues to prohibit a cruise ship
operator from commencing or
continuing any regular passenger
operations without a COVID–19
Conditional Sailing Certificate issued by
HHS/CDC. This information collection
request outlines the reporting and
document retention requirements that
are part of a phased approach to
resuming passenger operations.
The CSO Extension builds upon the
phased-in approach to resume cruise
ship passenger operations introduced by
the CSO. Cruise ship operators who
have already completed the process
under the CSO will not have to resubmit
any information under the CSO
Extension and can continue sailing with
passengers without interruption. As
many cruise ship operators are now
familiar with the CSO and its
requirements, many aspects of the
phased-in approach can be completed
concurrently under the CSO Extension.
Phase 1
Per CDC’s CSO Extension, cruise
ships operating or intending to operate
in U.S. waters must acknowledge that a
complete and accurate COVID–19
response plan (formerly referred to as
‘‘No Sail Order (NSO) response plan’’) is
observed. The COVID–19 response plan,
which can be submitted by a cruise ship
holding company and apply to all cruise
ships operated by the holding
company’s brands, must include: (1)
Terminology and use of definitions that
align with how CDC uses and defines
the following terms: ‘‘confirmed
COVID–19,’’ ‘‘COVID–19-like illness,’’
‘‘close contact,’’ ‘‘fully vaccinated for
COVID–19,’’ and ‘‘isolation’’ and
‘‘quarantine’’ (including timeframes for
isolation and quarantine); (2) protocols
for on board surveillance of passengers
and crew with COVID–19 and COVID–
VerDate Sep<11>2014
18:17 Oct 28, 2021
Jkt 256001
19-like illness; (3) protocols for training
all crew on COVID–19 prevention,
mitigation, and response activities; (4)
protocols for on board isolation and
quarantine, including how to increase
capacity in case of an outbreak; (5)
protocols for COVID–19 testing that
aligns with CDC technical instructions;
(6) protocols for onboard medical
staffing—including number and type of
staff—and equipment in sufficient
quantity to provide a hospital level of
care (e.g., ventilators, face masks,
personal protective equipment) for the
infected without the immediate need to
rely on shoreside hospitalization; and
(7) procedures for disembarkation of
passengers who test positive for COVID–
19.
Phase 1 also includes requirements
for COVID–19 testing capabilities and
reporting for cruise ship operators
operating or intending to operate cruise
ships in U.S. waters. Cruise ship
operators must have onboard testing
capabilities to test all symptomatic crew
and passengers for COVID–19 and their
close contacts. This includes having
onboard rapid nucleic acid
amplification test (NAAT) point-of-care
equipment that meets the requirements
specified by CDC in technical
instructions or orders and have received
CDC approval. For the Phase 1 mass
crew testing requirement, cruise ship
operators may use an onboard viral test
(NAAT or antigen test) or arrange
shoreside testing at a Clinical
Laboratory Improvement Amendments
(CLIA)-certified laboratory so long as it
meets the requirements specified by
CDC in technical instructions or orders
and have received CDC approval.
Finally, Phase 1 also includes
reporting requirements using the CDC
Enhanced Data Collection during
COVID–19 Pandemic (EDC) form. In lieu
of submitting the Maritime Conveyance
Cumulative Influenza/Influenza-Like
Illness (ILI) Form for COVID–19-like
illness and the Maritime Conveyance
Illness or the Death Investigation Form
for individual specific cases of COVID–
19, the CDC will require daily
submission of the EDC form during the
period of the CSO Extension. Data
points for this form include number of
travelers (crew and passengers)
currently onboard; case counts and
diagnostic testing data for COVID–19
and COVID–19-like Illness (CLI);
screening and testing of asymptomatic
travelers, isolation practices, and the
percentage of travelers who are fully
vaccinated. The data collected in the
EDC form are used to inform CDC’s
COVID–19 Color-Coding System for
Cruise Ships. This data will greatly
increase the transparency of the overall
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
health of the crew members and
passengers, and better allow the CDC to
manage potential outbreaks and offer
recommendations to the ship and port
partners. The color-coding system is
only applicable to cruise ships operating
or planning to operate in U.S. waters.
Status of ships is contingent upon daily
submission of the EDC form. When a
cruise ship notifies CDC of suspected or
confirmed cases of COVID–19 on board,
CDC determines whether an
investigation is needed based on a
predetermined threshold. If an
investigation is deemed necessary, CDC
will solicit extra information from the
cruise ship operator. This investigation
gives CDC and the cruise industry the
ability to work closely together to
protect the health and safety of those on
board and in communities.
Phase 2A
The next phase, Phase 2A, focuses on
preparation for simulated and restricted
voyages. As required under the CSO
Extension, a cruise ship operator’s
agreement with U.S. port authorities
and local health authorities must
include the following elements: (1) A
port agreement between the cruise ship
operator and port authority that takes
into consideration the public health
response resources of the jurisdiction in
the event of a COVID–19 outbreak, a
plan and timeline for vaccination of
cruise ship crew prior to resuming
passenger operations, and vaccination
strategies to maximally protect
passengers and crew from introduction,
amplification, and spread of COVID–19
in the maritime environment and in
land-based communities; (2) medical
care agreements between the cruise ship
operator and health care entities,
addressing evacuation and medical
transport to onshore hospitals for
passengers and crew in need of medical
care, in accordance with CDC technical
instructions and orders; and (3) housing
agreements between the cruise ship
operator and one or more shoreside
facilities for isolation and quarantine of
passengers or crew members with
COVID–19 and their close contacts,
identified from the day of embarkation
through disembarkation for each voyage.
Cruise lines/brands may submit these
agreements for all the ships in their
fleet. Note, these agreements can remain
in place for restricted voyages, as long
as the agreements remain valid.
In lieu of documenting the approval
of all local health authorities of
jurisdiction, the cruise ship operator
may instead submit to CDC a signed
statement from a local health authority,
on the health authority’s official
letterhead, indicating that the health
E:\FR\FM\29OCN1.SGM
29OCN1
Federal Register / Vol. 86, No. 207 / Friday, October 29, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
authority has declined to participate in
deliberations and/or sign the port
agreement (i.e., a ‘‘Statement of NonParticipation’’). Additionally, the cruise
ship operator may enter into a multiport agreement (as opposed to a single
port agreement) provided that all
relevant port and local health
authorities (including the state health
authorities) are signatories to the
agreement.
During discussions with cruise ship
operators, port authorities, and state and
local health authorities, all parties
requested CDC assistance with the
required agreements. In response to
these requests, CDC has posted specific
guidance online and has provided a
checklist for additional reference.
Phase 2B
Phase 2B of the CSO Extension
establishes the requirements for
simulated voyages where volunteers
play the role of passengers to test cruise
ship operators’ ability to mitigate
COVID–19 onboard. Passengers on
simulated voyages must be at least 12
years old, provide their informed
consent, and submit a medical
certification to the cruise ship operator
prior to embarkation.
Before conducting a simulated
voyage, a cruise ship operator must
submit a Request for Approval to
Conduct a Simulated Voyage Prior to
Issuance of COVID–19 Conditional
Sailing Certificate at least five business
days prior to the voyage. A cruise ship
operator shall not apply for approval to
conduct a simulated voyage until all of
CDC’s requirements relating to onboard
laboratory capacity and screening
testing of crew in U.S. waters have been
satisfied.
A simulated voyage must include the
following simulated activities: (1)
Embarkation and disembarkation
procedures, including terminal checkin, (2) on board activities, including at
dining and entertainment venues, (3)
private island shore excursions, if any
are planned during restricted passenger
voyages, (4) evacuation procedures, (5)
transfer of symptomatic passengers or
crew, or those who test positive for
SARS-CoV–2, from cabins to isolation
rooms, (6) quarantine of all remaining
passengers and non-essential crew, and
(7) other activities as may be listed in
CDC technical instructions and orders.
Additionally, the cruise ship operator
must: (1) Meet standards for hand
hygiene, facemasks, and physical
distancing for passengers and crew, as
well as ship sanitation, as may be
required by CDC technical instructions
or orders, (2) conduct laboratory testing
of all passengers and crew on the day of
VerDate Sep<11>2014
18:17 Oct 28, 2021
Jkt 256001
embarkation and the day of
disembarkation as required by CDC
technical instructions or orders, and (3)
immediately conduct laboratory testing
of any passengers and crew who report
illness consistent with COVID–19
during the simulated voyage with rapid
point-of-care results as required by CDC
technical instructions or orders. Note,
CDC may require the cruise ship
operator to immediately end the
simulated voyage and take other action
to protect the health and safety of
volunteer passengers and crew if during
the simulation a threshold of COVID–19
cases, as determined by CDC in
technical instructions, is met or
exceeded.
During simulated voyages, the cruise
ships are subject to virtual and inperson inspections by CDC. The cruise
ship operator’s properties and records
must be made available for inspection to
allow CDC to ascertain compliance with
its requirements. Such properties and
records include but are not limited to
vessels, facilities, vehicles, equipment,
communications, manifests, list of
passengers, laboratory test results, and
employee and passenger health records.
CDC has issued additional technical
guidance outlining the specific areas
that may be inspected and
corresponding recommendations.
Following each simulated voyage, the
cruise ship operator must document any
deficiencies in its health and safety
protocols through a Simulated Voyage
After-Action Report and address how
the cruise ship operator intends to
address those deficiencies. This AfterAction Report must also include
COVID–19 test results for any volunteer
passengers or crew on the simulated
voyage. The After-Action Report must
be submitted to the CDC as soon as
practicable at the end of the simulation
and as part of the cruise ship operator’s
application for a COVID–19 Conditional
Sailing Certificate.
In lieu of conducting a simulated
voyage, a cruise ship operator’s
responsible officials, at their discretion,
may sign and submit to CDC an
acknowledgement that 95% of crew
(excluding any newly embarking crew
in quarantine) are fully vaccinated and
submit to CDC a clear and specific
vaccination plan and timeline to limit
cruise ship sailings to 95% of
passengers who have been verified by
the cruise ship operator as fully
vaccinated prior to sailing.
Furthermore, cruise ships that have
been operating restricted passenger
voyages under an Acknowledgement by
a Cruise Ship Operator In Lieu of a
Simulated Voyage may, at their
discretion, transition to operating
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
60045
restricted passenger voyages with less
than 95% of passengers fully vaccinated
without first conducting a simulated
voyage if the following are met: (1) The
ship must maintain a percentage of fully
vaccinated crew that is greater than or
equal to 95%. (2) The ship must have
operated on restricted passenger
voyages under an acknowledgement by
the cruise ship operator’s responsible
officials that they will only operate with
95% of crew (excluding any newly
embarking crew in quarantine) and 95%
of passengers who are fully vaccinated
for at least 60 days. (3) At least 14 days
prior to the transition to voyages with
less than 95% of passengers fully
vaccinated, the cruise ship operator
must submit the following to CDC: (1)
Protocols for how dining and
entertainment venues, and recreational
activities including buffets, seated
dining, bars (including between
bartenders and patrons), theaters, other
performance venues, casinos, arcade
room, spa services, fitness classes/
gymnasiums, muster drills, and other
areas where passengers congregate will
be modified to incorporate mask use,
physical distancing, and other public
health measures as outlined in CDC
technical instructions. (2) Plans for
training crew on new procedures for
mask use, physical distancing, and other
public health measures as outlined in
CDC technical instructions. (3) Protocols
for increasing the number of isolation
and quarantine cabins and on-board
support staff (e.g., administrative
personnel, testing personnel, contact
tracers, medical personnel) as
determined by the cruise ship operator
and as needed in the event of an
outbreak. (4) Procedures for how crew
will identify and distinguish between
passengers who are fully vaccinated and
passengers who are not fully vaccinated.
(5) Procedures for notifying passengers
who booked a 95% passenger
vaccinated cruise that their cruise will
no longer operate as a 95% passenger
vaccinated cruise. (6) The cruise ship
operator must submit photographs or
videos, no later than seven days after
commencing the first voyage with less
than 95% of passengers fully
vaccinated, showing compliance with
indoor mask use and physical
distancing, such as signage in elevators,
dining table arrangements, and blocking
out seats/bar stools.
Similarly, cruise ship operators that
have been conducting passenger
operations outside of U.S. waters and
intend to operate cruise ships with less
than 95% of passengers fully vaccinated
after repositioning to U.S. waters may,
at their discretion, follow the
E:\FR\FM\29OCN1.SGM
29OCN1
60046
Federal Register / Vol. 86, No. 207 / Friday, October 29, 2021 / Notices
procedures in this paragraph for
conducting a modified simulated voyage
instead of conducting a full simulated
voyage if the following are met: (1) The
ship must maintain a percentage of fully
vaccinated crew that is greater than or
equal to 95%. (2) The ship must have
operated with passengers outside of U.S.
waters for at least 60 days before
entering U.S. waters. (3) The cruise ship
operator must conduct at least one
simulation of embarkation screening
and testing at the port terminal it
intends to use in the U.S.—to include
the number of passengers not fully
vaccinated expected on the first
voyage—unless the ship will be
operating at the terminal already in use
by the same cruise line/brand for
passenger operations. (4) At least 14
days prior to entering U.S. waters, the
cruise ship operator must submit the
following to CDC: (i) Protocols for how
dining and entertainment venues, and
recreational activities, including buffets,
seated dining, bars (including between
bartenders and patrons), theaters, other
performance venues, casinos, arcade
room, spa services, fitness classes/
gymnasiums, muster drills, and other
areas where passengers congregate will
incorporate mask use, physical
distancing, and other public health
measures as outlined in technical
instructions. (ii) Plans for training crew
on procedures for mask use, physical
distancing, and other public health
measures as outlined in CDC technical
instructions. (iii) Protocols for
increasing the number of isolation and
quarantine cabins and on-board support
staff (e.g., administrative personnel,
testing personnel, contact tracers,
medical personnel) as determined by
the cruise ship operator and as needed
in the event an outbreak. (iv) Procedures
for how crew will identify and
distinguish between passengers who are
fully vaccinated and passengers who are
not fully vaccinated. (v) Procedures for
notifying passengers who booked a 95%
vaccinated cruise that their cruise will
no longer operate as a 95% vaccinated
cruise, if applicable. (vi) An after-action
report explaining lessons learned from
sailing outside of U.S. waters and from
the simulated embarkation screening
and testing (if such a simulation was
conducted). (vii) The cruise ship
operator must submit photographs or
videos, no later than seven days after
commencing the first voyage with less
than 95% of passengers fully
vaccinated, showing compliance with
indoor mask use and physical
distancing, such as signage in elevators,
dining table arrangements, and blocking
out seats/bar stools.
Phase 3
As a condition of applying for a
COVID–19 Conditional Sailing
Certificate (Phase 3), a cruise ship
operator must have successfully
conducted a simulated voyage,
submitted an Acknowledgement by a
Cruise Ship Operator In Lieu of a
Simulated Voyage, or—if applicable—
completed the specific modified
simulated voyage procedures described
above. The CDC COVID–19 Conditional
Sailing Certificate Application must
include: (1) A completed CDC
registration/application form that
includes the signatures of the cruise
ship operator’s responsible officials; (2)
The name, titles, and contact
information for the cruise ship
operator’s responsible officials; (3) A
completed statement of intent stating
the name, carrying capacity for
passengers and crew, itinerary, ports of
call, length of voyage, and expected
onboard or shoreside activities, for the
cruise ship that the cruise ship operator
intends to have certified for restricted
passenger operations; (4) a certification
statement signed by the responsible
officials attesting that the cruise ship
operator has complied and remains in
compliance with CDC’s requirements for
a COVID–19 Response Plan and EDC
reporting prior to applying for a COVID–
19 Conditional Sailing Certificate; (5) a
certification statement signed by the
responsible officials attesting that the
cruise ship operator has adopted health
and safety protocols that meet CDC’s
standards for mitigating the risk of
COVID–19 among passengers and crew
onboard the cruise ship that will be
commencing restricted passenger
operations, and will modify these
protocols as needed to protect the
public’s health as required by CDC
technical instructions or orders; (6) a
certification statement signed by the
responsible officials attesting that the
cruise ship operator has sufficient
medical and point of care laboratory
capabilities and staff on board the cruise
ship that will be commencing restricted
passenger operations to manage severe
COVID–19 cases and outbreaks in
exigent circumstances as required by
CDC technical instructions or orders;
and (7) a certification statement signed
by the responsible officials attesting that
the cruise ship operator is in
compliance with the other requirements
contained in this framework for
mitigating the risk of COVID–19 on
board cruise ships and agrees to
continue to comply with these
requirements.
These documents must be submitted
at least five business days prior to any
proposed restricted voyage. If the
Certificate is denied, revoked or
suspended, a cruise ship operator may
submit a written appeal of a denial of
its application for a COVID–19
Conditional Sailing Certificate or a
revocation or suspension of its COVID–
19 Conditional Sailing Certificate.
During restricted voyages, the cruise
ships are subject to virtual and inperson inspections by CDC. The cruise
ship operator’s properties and records
must be made available for inspection to
allow CDC to ascertain compliance with
its requirements. Such properties and
records include but are not limited to
vessels, facilities, vehicles, equipment,
communications, manifests, list of
passengers, laboratory test results, and
employee and passenger health records.
CDC has issued additional technical
guidance outlining the specific areas
that may be inspected and
corresponding recommendations. CDC
has provided, and will continue to
provide, the technical instructions for
each phase as they are released through
a non-substantive change request.
CDC requests OMB approval for an
estimated 24,146 annual burden hours
to respondents and record keepers.
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Cruise ship holding company .......
Cruise ship physician ....................
COVID–19 Response Plan ..............................................
Enhanced Data Collection (EDC) During COVID–19
Pandemic Form (Daily).
Cruise COVID–19 Case Investigation Worksheet (if necessary).
Cruise ship physician ....................
VerDate Sep<11>2014
18:17 Oct 28, 2021
Jkt 256001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\29OCN1.SGM
Number
responses per
respondent
Average
burden per
response
(in hrs.)
3
130
1
365
2400/60
20/60
104
1
30/60
29OCN1
60047
Federal Register / Vol. 86, No. 207 / Friday, October 29, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Cruise ship physician ....................
Cruise COVID–19 Contact Investigation Worksheet (if
necessary).
Approval of Onboard COVID–19 Testing Instrument ......
Mass Crew Testing Requirement ....................................
Agreement with Health Care Organization with signoff
from Local Health Authorities.
Agreement with Port of Entry with signoff from Local
Health Authority.
Agreement with Housing Facility with signoff from Local
Health Authority.
Request for Approval to Conduct a Simulated Voyage
Prior to Issuance of COVID–19 Conditional Sailing
Certificate.
Informed Consent and Medical Certification with no preexisting conditions for Simulated Voyage.
Remote and In-person Inspections ..................................
After Action Report, Simulated Voyage ...........................
COVID–19 Conditional Sailing Certificate Application .....
Remote and In-person Inspections ..................................
Cruise ship brand/operator ...........
Cruise ship brand/operator ...........
Cruise ship brand/operator ...........
Cruise ship brand/operator ...........
Cruise ship brand/operator ...........
Cruise ship operator .....................
Passenger (3rd party disclosure) ..
Cruise
Cruise
Cruise
Cruise
ship
ship
ship
ship
operator
operator
operator
operator
.....................
.....................
.....................
.....................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–23555 Filed 10–28–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0017; Docket No. CDC–2021–
0116]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Application for Training, which
supports the management and
evaluation of online training and
professional development opportunities
for public health and health care
professionals.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
VerDate Sep<11>2014
18:17 Oct 28, 2021
Jkt 256001
CDC must receive written
comments on or before December 28,
2021.
DATES:
You may submit comments,
identified by Docket No. CDC–2021–
0116 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
ADDRESSES:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Number
responses per
respondent
Average
burden per
response
(in hrs.)
24
1
30/60
60
60
60
1
1
1
60/60
5/60
600/60
60
1
600/60
60
1
600/60
30
1
600/60
18,000
1
15/60
30
30
60
130
1
1
1
2
120/60
600/60
600/60
120/60
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Application for Training—(OMB
Control No. 0920–0017, Exp. 04/30/
2022)—Revision—Center for
Surveillance, Epidemiology, and
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 86, Number 207 (Friday, October 29, 2021)]
[Notices]
[Pages 60043-60047]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23555]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1355]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) submitted the information
collection request titled Phased Approach to the Resumption of Cruise
Ship Passenger Operations to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' on April
30, 2021, to obtain comments from the public and affected agencies.
This collection accompanies a CDC Order entitled Temporary Extension
and Modification of Framework for Conditional Sailing Order (CSO). CDC
received twenty (20) comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden
of the proposed collection of information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information
to be collected;
(d) Minimize the burden of the collection of information on
those who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g.,
permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th
[[Page 60044]]
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Phased Approach to the Resumption of Cruise Ship Passenger
Operations (OMB Control No. 0920-1335, Exp. 10/31/2021)--Extension--
National Center for Emerging Zoonotic and Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Temporary Extension and Modification Framework for Conditional
Sailing Order (here on referred to as the ``CSO Extension'') extends
The Framework for Conditional Sailing Order published in the Federal
Register on November 4, 2020, and continues to prohibit a cruise ship
operator from commencing or continuing any regular passenger operations
without a COVID-19 Conditional Sailing Certificate issued by HHS/CDC.
This information collection request outlines the reporting and document
retention requirements that are part of a phased approach to resuming
passenger operations.
The CSO Extension builds upon the phased-in approach to resume
cruise ship passenger operations introduced by the CSO. Cruise ship
operators who have already completed the process under the CSO will not
have to resubmit any information under the CSO Extension and can
continue sailing with passengers without interruption. As many cruise
ship operators are now familiar with the CSO and its requirements, many
aspects of the phased-in approach can be completed concurrently under
the CSO Extension.
Phase 1
Per CDC's CSO Extension, cruise ships operating or intending to
operate in U.S. waters must acknowledge that a complete and accurate
COVID-19 response plan (formerly referred to as ``No Sail Order (NSO)
response plan'') is observed. The COVID-19 response plan, which can be
submitted by a cruise ship holding company and apply to all cruise
ships operated by the holding company's brands, must include: (1)
Terminology and use of definitions that align with how CDC uses and
defines the following terms: ``confirmed COVID-19,'' ``COVID-19-like
illness,'' ``close contact,'' ``fully vaccinated for COVID-19,'' and
``isolation'' and ``quarantine'' (including timeframes for isolation
and quarantine); (2) protocols for on board surveillance of passengers
and crew with COVID-19 and COVID-19-like illness; (3) protocols for
training all crew on COVID-19 prevention, mitigation, and response
activities; (4) protocols for on board isolation and quarantine,
including how to increase capacity in case of an outbreak; (5)
protocols for COVID-19 testing that aligns with CDC technical
instructions; (6) protocols for onboard medical staffing--including
number and type of staff--and equipment in sufficient quantity to
provide a hospital level of care (e.g., ventilators, face masks,
personal protective equipment) for the infected without the immediate
need to rely on shoreside hospitalization; and (7) procedures for
disembarkation of passengers who test positive for COVID-19.
Phase 1 also includes requirements for COVID-19 testing
capabilities and reporting for cruise ship operators operating or
intending to operate cruise ships in U.S. waters. Cruise ship operators
must have onboard testing capabilities to test all symptomatic crew and
passengers for COVID-19 and their close contacts. This includes having
onboard rapid nucleic acid amplification test (NAAT) point-of-care
equipment that meets the requirements specified by CDC in technical
instructions or orders and have received CDC approval. For the Phase 1
mass crew testing requirement, cruise ship operators may use an onboard
viral test (NAAT or antigen test) or arrange shoreside testing at a
Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory
so long as it meets the requirements specified by CDC in technical
instructions or orders and have received CDC approval.
Finally, Phase 1 also includes reporting requirements using the CDC
Enhanced Data Collection during COVID-19 Pandemic (EDC) form. In lieu
of submitting the Maritime Conveyance Cumulative Influenza/Influenza-
Like Illness (ILI) Form for COVID-19-like illness and the Maritime
Conveyance Illness or the Death Investigation Form for individual
specific cases of COVID-19, the CDC will require daily submission of
the EDC form during the period of the CSO Extension. Data points for
this form include number of travelers (crew and passengers) currently
onboard; case counts and diagnostic testing data for COVID-19 and
COVID-19-like Illness (CLI); screening and testing of asymptomatic
travelers, isolation practices, and the percentage of travelers who are
fully vaccinated. The data collected in the EDC form are used to inform
CDC's COVID-19 Color-Coding System for Cruise Ships. This data will
greatly increase the transparency of the overall health of the crew
members and passengers, and better allow the CDC to manage potential
outbreaks and offer recommendations to the ship and port partners. The
color-coding system is only applicable to cruise ships operating or
planning to operate in U.S. waters. Status of ships is contingent upon
daily submission of the EDC form. When a cruise ship notifies CDC of
suspected or confirmed cases of COVID-19 on board, CDC determines
whether an investigation is needed based on a predetermined threshold.
If an investigation is deemed necessary, CDC will solicit extra
information from the cruise ship operator. This investigation gives CDC
and the cruise industry the ability to work closely together to protect
the health and safety of those on board and in communities.
Phase 2A
The next phase, Phase 2A, focuses on preparation for simulated and
restricted voyages. As required under the CSO Extension, a cruise ship
operator's agreement with U.S. port authorities and local health
authorities must include the following elements: (1) A port agreement
between the cruise ship operator and port authority that takes into
consideration the public health response resources of the jurisdiction
in the event of a COVID-19 outbreak, a plan and timeline for
vaccination of cruise ship crew prior to resuming passenger operations,
and vaccination strategies to maximally protect passengers and crew
from introduction, amplification, and spread of COVID-19 in the
maritime environment and in land-based communities; (2) medical care
agreements between the cruise ship operator and health care entities,
addressing evacuation and medical transport to onshore hospitals for
passengers and crew in need of medical care, in accordance with CDC
technical instructions and orders; and (3) housing agreements between
the cruise ship operator and one or more shoreside facilities for
isolation and quarantine of passengers or crew members with COVID-19
and their close contacts, identified from the day of embarkation
through disembarkation for each voyage. Cruise lines/brands may submit
these agreements for all the ships in their fleet. Note, these
agreements can remain in place for restricted voyages, as long as the
agreements remain valid.
In lieu of documenting the approval of all local health authorities
of jurisdiction, the cruise ship operator may instead submit to CDC a
signed statement from a local health authority, on the health
authority's official letterhead, indicating that the health
[[Page 60045]]
authority has declined to participate in deliberations and/or sign the
port agreement (i.e., a ``Statement of Non-Participation'').
Additionally, the cruise ship operator may enter into a multi-port
agreement (as opposed to a single port agreement) provided that all
relevant port and local health authorities (including the state health
authorities) are signatories to the agreement.
During discussions with cruise ship operators, port authorities,
and state and local health authorities, all parties requested CDC
assistance with the required agreements. In response to these requests,
CDC has posted specific guidance online and has provided a checklist
for additional reference.
Phase 2B
Phase 2B of the CSO Extension establishes the requirements for
simulated voyages where volunteers play the role of passengers to test
cruise ship operators' ability to mitigate COVID-19 onboard. Passengers
on simulated voyages must be at least 12 years old, provide their
informed consent, and submit a medical certification to the cruise ship
operator prior to embarkation.
Before conducting a simulated voyage, a cruise ship operator must
submit a Request for Approval to Conduct a Simulated Voyage Prior to
Issuance of COVID-19 Conditional Sailing Certificate at least five
business days prior to the voyage. A cruise ship operator shall not
apply for approval to conduct a simulated voyage until all of CDC's
requirements relating to onboard laboratory capacity and screening
testing of crew in U.S. waters have been satisfied.
A simulated voyage must include the following simulated activities:
(1) Embarkation and disembarkation procedures, including terminal
check-in, (2) on board activities, including at dining and
entertainment venues, (3) private island shore excursions, if any are
planned during restricted passenger voyages, (4) evacuation procedures,
(5) transfer of symptomatic passengers or crew, or those who test
positive for SARS-CoV-2, from cabins to isolation rooms, (6) quarantine
of all remaining passengers and non-essential crew, and (7) other
activities as may be listed in CDC technical instructions and orders.
Additionally, the cruise ship operator must: (1) Meet standards for
hand hygiene, facemasks, and physical distancing for passengers and
crew, as well as ship sanitation, as may be required by CDC technical
instructions or orders, (2) conduct laboratory testing of all
passengers and crew on the day of embarkation and the day of
disembarkation as required by CDC technical instructions or orders, and
(3) immediately conduct laboratory testing of any passengers and crew
who report illness consistent with COVID-19 during the simulated voyage
with rapid point-of-care results as required by CDC technical
instructions or orders. Note, CDC may require the cruise ship operator
to immediately end the simulated voyage and take other action to
protect the health and safety of volunteer passengers and crew if
during the simulation a threshold of COVID-19 cases, as determined by
CDC in technical instructions, is met or exceeded.
During simulated voyages, the cruise ships are subject to virtual
and in-person inspections by CDC. The cruise ship operator's properties
and records must be made available for inspection to allow CDC to
ascertain compliance with its requirements. Such properties and records
include but are not limited to vessels, facilities, vehicles,
equipment, communications, manifests, list of passengers, laboratory
test results, and employee and passenger health records. CDC has issued
additional technical guidance outlining the specific areas that may be
inspected and corresponding recommendations. Following each simulated
voyage, the cruise ship operator must document any deficiencies in its
health and safety protocols through a Simulated Voyage After-Action
Report and address how the cruise ship operator intends to address
those deficiencies. This After-Action Report must also include COVID-19
test results for any volunteer passengers or crew on the simulated
voyage. The After-Action Report must be submitted to the CDC as soon as
practicable at the end of the simulation and as part of the cruise ship
operator's application for a COVID-19 Conditional Sailing Certificate.
In lieu of conducting a simulated voyage, a cruise ship operator's
responsible officials, at their discretion, may sign and submit to CDC
an acknowledgement that 95% of crew (excluding any newly embarking crew
in quarantine) are fully vaccinated and submit to CDC a clear and
specific vaccination plan and timeline to limit cruise ship sailings to
95% of passengers who have been verified by the cruise ship operator as
fully vaccinated prior to sailing.
Furthermore, cruise ships that have been operating restricted
passenger voyages under an Acknowledgement by a Cruise Ship Operator In
Lieu of a Simulated Voyage may, at their discretion, transition to
operating restricted passenger voyages with less than 95% of passengers
fully vaccinated without first conducting a simulated voyage if the
following are met: (1) The ship must maintain a percentage of fully
vaccinated crew that is greater than or equal to 95%. (2) The ship must
have operated on restricted passenger voyages under an acknowledgement
by the cruise ship operator's responsible officials that they will only
operate with 95% of crew (excluding any newly embarking crew in
quarantine) and 95% of passengers who are fully vaccinated for at least
60 days. (3) At least 14 days prior to the transition to voyages with
less than 95% of passengers fully vaccinated, the cruise ship operator
must submit the following to CDC: (1) Protocols for how dining and
entertainment venues, and recreational activities including buffets,
seated dining, bars (including between bartenders and patrons),
theaters, other performance venues, casinos, arcade room, spa services,
fitness classes/gymnasiums, muster drills, and other areas where
passengers congregate will be modified to incorporate mask use,
physical distancing, and other public health measures as outlined in
CDC technical instructions. (2) Plans for training crew on new
procedures for mask use, physical distancing, and other public health
measures as outlined in CDC technical instructions. (3) Protocols for
increasing the number of isolation and quarantine cabins and on-board
support staff (e.g., administrative personnel, testing personnel,
contact tracers, medical personnel) as determined by the cruise ship
operator and as needed in the event of an outbreak. (4) Procedures for
how crew will identify and distinguish between passengers who are fully
vaccinated and passengers who are not fully vaccinated. (5) Procedures
for notifying passengers who booked a 95% passenger vaccinated cruise
that their cruise will no longer operate as a 95% passenger vaccinated
cruise. (6) The cruise ship operator must submit photographs or videos,
no later than seven days after commencing the first voyage with less
than 95% of passengers fully vaccinated, showing compliance with indoor
mask use and physical distancing, such as signage in elevators, dining
table arrangements, and blocking out seats/bar stools.
Similarly, cruise ship operators that have been conducting
passenger operations outside of U.S. waters and intend to operate
cruise ships with less than 95% of passengers fully vaccinated after
repositioning to U.S. waters may, at their discretion, follow the
[[Page 60046]]
procedures in this paragraph for conducting a modified simulated voyage
instead of conducting a full simulated voyage if the following are met:
(1) The ship must maintain a percentage of fully vaccinated crew that
is greater than or equal to 95%. (2) The ship must have operated with
passengers outside of U.S. waters for at least 60 days before entering
U.S. waters. (3) The cruise ship operator must conduct at least one
simulation of embarkation screening and testing at the port terminal it
intends to use in the U.S.--to include the number of passengers not
fully vaccinated expected on the first voyage--unless the ship will be
operating at the terminal already in use by the same cruise line/brand
for passenger operations. (4) At least 14 days prior to entering U.S.
waters, the cruise ship operator must submit the following to CDC: (i)
Protocols for how dining and entertainment venues, and recreational
activities, including buffets, seated dining, bars (including between
bartenders and patrons), theaters, other performance venues, casinos,
arcade room, spa services, fitness classes/gymnasiums, muster drills,
and other areas where passengers congregate will incorporate mask use,
physical distancing, and other public health measures as outlined in
technical instructions. (ii) Plans for training crew on procedures for
mask use, physical distancing, and other public health measures as
outlined in CDC technical instructions. (iii) Protocols for increasing
the number of isolation and quarantine cabins and on-board support
staff (e.g., administrative personnel, testing personnel, contact
tracers, medical personnel) as determined by the cruise ship operator
and as needed in the event an outbreak. (iv) Procedures for how crew
will identify and distinguish between passengers who are fully
vaccinated and passengers who are not fully vaccinated. (v) Procedures
for notifying passengers who booked a 95% vaccinated cruise that their
cruise will no longer operate as a 95% vaccinated cruise, if
applicable. (vi) An after-action report explaining lessons learned from
sailing outside of U.S. waters and from the simulated embarkation
screening and testing (if such a simulation was conducted). (vii) The
cruise ship operator must submit photographs or videos, no later than
seven days after commencing the first voyage with less than 95% of
passengers fully vaccinated, showing compliance with indoor mask use
and physical distancing, such as signage in elevators, dining table
arrangements, and blocking out seats/bar stools.
Phase 3
As a condition of applying for a COVID-19 Conditional Sailing
Certificate (Phase 3), a cruise ship operator must have successfully
conducted a simulated voyage, submitted an Acknowledgement by a Cruise
Ship Operator In Lieu of a Simulated Voyage, or--if applicable--
completed the specific modified simulated voyage procedures described
above. The CDC COVID-19 Conditional Sailing Certificate Application
must include: (1) A completed CDC registration/application form that
includes the signatures of the cruise ship operator's responsible
officials; (2) The name, titles, and contact information for the cruise
ship operator's responsible officials; (3) A completed statement of
intent stating the name, carrying capacity for passengers and crew,
itinerary, ports of call, length of voyage, and expected onboard or
shoreside activities, for the cruise ship that the cruise ship operator
intends to have certified for restricted passenger operations; (4) a
certification statement signed by the responsible officials attesting
that the cruise ship operator has complied and remains in compliance
with CDC's requirements for a COVID-19 Response Plan and EDC reporting
prior to applying for a COVID-19 Conditional Sailing Certificate; (5) a
certification statement signed by the responsible officials attesting
that the cruise ship operator has adopted health and safety protocols
that meet CDC's standards for mitigating the risk of COVID-19 among
passengers and crew onboard the cruise ship that will be commencing
restricted passenger operations, and will modify these protocols as
needed to protect the public's health as required by CDC technical
instructions or orders; (6) a certification statement signed by the
responsible officials attesting that the cruise ship operator has
sufficient medical and point of care laboratory capabilities and staff
on board the cruise ship that will be commencing restricted passenger
operations to manage severe COVID-19 cases and outbreaks in exigent
circumstances as required by CDC technical instructions or orders; and
(7) a certification statement signed by the responsible officials
attesting that the cruise ship operator is in compliance with the other
requirements contained in this framework for mitigating the risk of
COVID-19 on board cruise ships and agrees to continue to comply with
these requirements.
These documents must be submitted at least five business days prior
to any proposed restricted voyage. If the Certificate is denied,
revoked or suspended, a cruise ship operator may submit a written
appeal of a denial of its application for a COVID-19 Conditional
Sailing Certificate or a revocation or suspension of its COVID-19
Conditional Sailing Certificate.
During restricted voyages, the cruise ships are subject to virtual
and in-person inspections by CDC. The cruise ship operator's properties
and records must be made available for inspection to allow CDC to
ascertain compliance with its requirements. Such properties and records
include but are not limited to vessels, facilities, vehicles,
equipment, communications, manifests, list of passengers, laboratory
test results, and employee and passenger health records. CDC has issued
additional technical guidance outlining the specific areas that may be
inspected and corresponding recommendations. CDC has provided, and will
continue to provide, the technical instructions for each phase as they
are released through a non-substantive change request.
CDC requests OMB approval for an estimated 24,146 annual burden
hours to respondents and record keepers.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Cruise ship holding company........ COVID-19 Response Plan..... 3 1 2400/60
Cruise ship physician.............. Enhanced Data Collection 130 365 20/60
(EDC) During COVID-19
Pandemic Form (Daily).
Cruise ship physician.............. Cruise COVID-19 Case 104 1 30/60
Investigation Worksheet
(if necessary).
[[Page 60047]]
Cruise ship physician.............. Cruise COVID-19 Contact 24 1 30/60
Investigation Worksheet
(if necessary).
Cruise ship brand/operator......... Approval of Onboard COVID- 60 1 60/60
19 Testing Instrument.
Cruise ship brand/operator......... Mass Crew Testing 60 1 5/60
Requirement.
Cruise ship brand/operator......... Agreement with Health Care 60 1 600/60
Organization with signoff
from Local Health
Authorities.
Cruise ship brand/operator......... Agreement with Port of 60 1 600/60
Entry with signoff from
Local Health Authority.
Cruise ship brand/operator......... Agreement with Housing 60 1 600/60
Facility with signoff from
Local Health Authority.
Cruise ship operator............... Request for Approval to 30 1 600/60
Conduct a Simulated Voyage
Prior to Issuance of COVID-
19 Conditional Sailing
Certificate.
Passenger (3rd party disclosure)... Informed Consent and 18,000 1 15/60
Medical Certification with
no pre-existing conditions
for Simulated Voyage.
Cruise ship operator............... Remote and In-person 30 1 120/60
Inspections.
Cruise ship operator............... After Action Report, 30 1 600/60
Simulated Voyage.
Cruise ship operator............... COVID-19 Conditional 60 1 600/60
Sailing Certificate
Application.
Cruise ship operator............... Remote and In-person 130 2 120/60
Inspections.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-23555 Filed 10-28-21; 8:45 am]
BILLING CODE 4163-18-P
